Betaxolol Market
According to Intent Market Research, the Betaxolol Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 6.0% to touch USD 1.1 billion by 2030. The Betaxolol Market is dominated by key players such as, Pfizer Inc., Novartis International AG, Mylan N.V., Cipla Inc., and Aurobindo Pharma.